Phase 1 Myelodysplastic Syndromes (MDS) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Acute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)

Beijing InnoCare Pharma Tech Co., Ltd.266 enrolled18 locationsNCT06656494

Recruiting

Phase 1

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.

Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)

Ascentage Pharma Group Inc.102 enrolled14 locationsNCT04275518